Profile data is unavailable for this security.
About the company
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
- Revenue in USD (TTM)5.83bn
- Net income in USD708.66m
- Incorporated2016
- Employees17.79k
- LocationSTERIS plc70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
Mergers & acquisitions
| Acquired company | STE:NYQ since announced | Transaction value |
|---|---|---|
| Medik Hospital Design GmbH | -9.15% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Globus Medical Inc | 2.94bn | 537.87m | 12.69bn | 6.00k | 23.84 | 2.77 | 15.55 | 4.32 | 3.93 | 3.93 | 21.44 | 33.86 | 0.5569 | 1.35 | 4.75 | 489,821.80 | 10.19 | 6.18 | 11.69 | 6.89 | 67.41 | 66.20 | 18.30 | 12.25 | 2.74 | -- | 0.0002 | 0.00 | 16.65 | 30.08 | 422.28 | 39.37 | 22.34 | -- |
| Penumbra Inc | 1.40bn | 177.69m | 13.43bn | 4.70k | 75.68 | 9.41 | 68.83 | 9.57 | 4.52 | 4.52 | 35.73 | 36.39 | 0.8356 | 1.10 | 7.85 | 298,652.10 | 10.58 | 4.03 | 11.77 | 4.49 | 67.14 | 64.57 | 12.66 | 5.39 | 4.29 | -- | 0.0159 | 0.00 | 17.50 | 20.16 | 1,168.11 | -- | 20.82 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.47bn | 20.29k | 33.40 | 3.33 | 20.80 | 3.34 | 5.66 | 5.66 | 55.59 | 56.74 | 0.6483 | 5.33 | 3.85 | 198,864.70 | 6.59 | 8.11 | 9.67 | 11.97 | 68.27 | 70.62 | 10.17 | 12.31 | 1.24 | -- | 0.00 | 0.00 | 0.899 | 10.30 | -2.61 | -25.40 | -7.94 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.37bn | 15.00k | 44.79 | 2.00 | 21.77 | 4.00 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.84bn | 7.07k | 31.31 | 3.21 | 20.07 | 4.08 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.71bn | 247.10m | 17.28bn | 5.40k | 70.12 | 11.40 | 51.18 | 6.38 | 3.50 | 3.50 | 37.86 | 21.53 | 0.8628 | 1.74 | 6.14 | 501,518.50 | 7.87 | 7.14 | 9.75 | 8.51 | 71.63 | 68.72 | 9.13 | 10.06 | 2.15 | 46.91 | 0.3852 | 0.00 | 30.73 | 24.53 | -40.93 | 105.15 | 5.67 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.10bn | 10.80k | 36.98 | 5.70 | 27.81 | 5.89 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.40 | 284,638.90 | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.0614 | 10.13 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 704.60m | 19.47bn | 17.00k | 28.06 | 1.53 | 10.82 | 2.36 | 3.55 | 3.55 | 41.44 | 64.95 | 0.3703 | 1.10 | 5.17 | 484,211.80 | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.71 | 0.3718 | 29.26 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.32bn | 8.60k | 24.26 | 7.47 | 18.14 | 4.68 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| Steris PLC | 5.83bn | 708.66m | 24.30bn | 17.79k | 34.48 | 3.40 | 20.30 | 4.17 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.66bn | 836.30m | 28.40bn | 11.00k | 35.71 | 10.34 | 26.10 | 6.09 | 2.07 | 2.07 | 11.50 | 7.14 | 0.727 | 3.02 | 4.20 | 423,818.20 | 13.04 | 8.85 | 21.58 | 12.58 | 62.09 | 63.92 | 17.94 | 14.21 | 1.59 | -- | 0.3204 | -- | 15.60 | 19.33 | 45.14 | 8.75 | 12.81 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 29.83bn | 7.29k | 35.29 | 4.24 | 33.14 | 9.68 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Waters Corp | 3.17bn | 642.63m | 30.14bn | 7.90k | 28.56 | 7.14 | 35.47 | 9.52 | 10.76 | 10.76 | 53.01 | 43.01 | 0.6574 | 2.46 | 4.05 | 400,669.10 | 13.35 | 17.03 | 16.91 | 21.51 | 59.28 | 59.00 | 20.30 | 22.40 | 1.27 | 15.81 | 0.3546 | 0.00 | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| Agilent Technologies Inc | 7.07bn | 1.29bn | 33.41bn | 18.10k | 26.09 | 4.84 | 21.24 | 4.73 | 4.53 | 4.53 | 24.81 | 24.44 | 0.5714 | 3.26 | 4.96 | 390,331.50 | 10.43 | 11.44 | 12.51 | 13.67 | 52.53 | 53.25 | 18.26 | 18.82 | 1.59 | 19.12 | 0.3268 | 20.76 | 6.73 | 5.41 | 1.09 | 12.63 | 27.88 | 7.10 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 11.31m | 11.53% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 5.78m | 5.89% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 4.61m | 4.70% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 3.26m | 3.32% |
| Morgan Stanley Investment Management Ltd.as of 31 Dec 2025 | 2.59m | 2.64% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.52m | 2.57% |
| Orbis Investment Management Ltd.as of 31 Dec 2025 | 2.13m | 2.17% |
| Generation Investment Management LLPas of 31 Dec 2025 | 2.09m | 2.13% |
| Select Equity Group LPas of 31 Dec 2025 | 1.93m | 1.96% |
| AQR Capital Management LLCas of 31 Dec 2025 | 1.62m | 1.65% |
